SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-021779
Filing Date
2021-03-18
Accepted
2021-03-18 16:50:39
Documents
2
Period of Report
2021-03-17

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1535
2 POA DOCUMENT poa.txt EX-24.3_974246 2973
  Complete submission text file 0001209191-21-021779.txt   5899
Mailing Address C/O NGM BIOPHARMACEUTICALS, INC. 333 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address
JONKER JEFFREY DAVID (Reporting) CIK: 0001589394 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39512 | Film No.: 21754967

Mailing Address 3985 SORRENTO VALLEY BLVD., SUITE C SAN DIEGO CA 92121
Business Address 3985 SORRENTO VALLEY BLVD., SUITE C SAN DIEGO CA 92121 858-369-7800
Metacrine, Inc. (Issuer) CIK: 0001634379 (see all company filings)

IRS No.: 472297384 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations